Walgreens' official earnings report for Q2 2025

Walgreens Q1 2025 Earnings Beat Estimates with $39.46B Revenue and $0.51 Adj EPS, Despite $245M Operating Loss

Jan 10, 2025, 12:14 PM

Walgreens Boots Alliance Inc. reported its fiscal 2025 first-quarter results, surpassing Wall Street's expectations across key financial metrics. The company achieved adjusted earnings per share of $0.51, beating the consensus estimate of $0.37, and reported revenue of $39.46 billion, exceeding the expected $37.34 billion. Sales growth was observed across all business segments, with a 7.5% year-over-year revenue increase, international sales reaching $6.43 billion with a 10.2% year-over-year increase, and U.S. retail pharmacy sales at $30.87 billion, up 6.6% year-over-year. Despite these strong results, Walgreens posted a pretax profit loss of $538 million and an operating loss of $245 million. The company's adjusted operating income was $593 million. Walgreens maintained its fiscal 2025 adjusted EPS guidance at $1.40 to $1.80, which is below the consensus estimate of $1.52. Following the earnings release, Walgreens' stock surged by 7%.